0000950129-05-000835.txt : 20120703 0000950129-05-000835.hdr.sgml : 20120703 20050202152537 ACCESSION NUMBER: 0000950129-05-000835 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20050202 DATE AS OF CHANGE: 20050202 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: COLEN LOUIS CENTRAL INDEX KEY: 0000903994 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: 2727 KRIMM DR CITY: LOS ANGELES STATE: CA ZIP: 90064 BUSINESS PHONE: 3015538441 MAIL ADDRESS: STREET 1: 2727 KRIM DRIVE CITY: LOS ANGELES STATE: CA ZIP: 90064 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: DIAGNOSTIC PRODUCTS CORP CENTRAL INDEX KEY: 0000702259 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 952802182 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-34645 FILM NUMBER: 05569219 BUSINESS ADDRESS: STREET 1: 5210 PACIFIC CONCOURSE DRIVE CITY: LOS ANGELES STATE: CA ZIP: 90045 BUSINESS PHONE: 3106458200 MAIL ADDRESS: STREET 1: 5210 PACIFIC CONCOURSE DRIVE CITY: LOS ANGELES STATE: CA ZIP: 90045 SC 13G/A 1 v05014sc13gza.txt SCHEDULE 13G/AMENDMENT NO. 13 SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G/A UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 13) DIAGNOSTIC PRODUCTS CORPORATION ------------------------------------------------ (Name of Issuer) COMMON STOCK, NO PAR VALUE ---------------------------------------------- (Title of Class of Securities) 252450-10-1 -------------------------------- (CUSIP Number) DECEMBER 31, 2004 ----------------------------------------- (Date of Event which Requires Filing This Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed. [ ] Rule 13d-1(b) [ ] Rule 13d-1(c) [x] Rule 13d-1(d) *The remainder of this cover page shall be filed out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13G CUSIP NO. 252450-10-1 1. NAME OF REPORTING PERSON LOUIS COLEN 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP. (A) [ ] (B) [ ] 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION U.S.A. NUMBER OF 5. SOLE VOTING POWER: 1,470,505 SHARES BENEFICIALLY 6. SHARED VOTING POWER: -0- OWNED BY EACH REPORTING 7. SOLE DISPOSITIVE POWER: 1,470,505 PERSON WITH 8. SHARED DISPOSITIVE POWER: -0- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,470,505 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES [ ] 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 5.03% 12. TYPE OF REPORTING PERSON IN Item 1(a) Name of Issuer: Diagnostic Products Corporation -------------- Item 1(b) Address of Issuer's Principal Executive Offices: ----------------------------------------------- 5210 Pacific Concourse Drive Los Angeles, California 90045 Item 2(a) Name of Person Filing: Louis Colen Item 2(b) Address: 2727 Krim Drive ------- Los Angeles, CA 90064 Item 2(c) Citizenship: U.S.A. ----------- Item 2(d) Title of Class of Securities: Common Stock ---------------------------- Item 2(e) CUSIP Number: 252450-10-1 ------------ Item 3 Statement filed Pursuant to Rules 13d-1(b) or 13(d)-2(b) or (c): --------------------------------------------------------------- Not Applicable Item 4(a) Amount Beneficially Owned: 1,470,505 shares ------------------------- Item 4(b) Percent of Class: 5.03% ---------------- Item 4(c) Number of shares as to which reporting person has: ------------------------------------------------- (i) sole power to vote or to direct the vote: 1,470,505 (ii) shared power to vote or to direct the vote: 0 (iii) sole power to dispose or to direct the disposition of: 1,470,505 (iv) shared power to dispose or to direct the disposition of: 0 Item 5 Ownership of 5% or Less of Class: Not Applicable -------------------------------- Item 6 Ownership of More than 5% on Behalf of Another Person: ----------------------------------------------------- Not Applicable Item 7 Identification and Classification of the Subsidiary which Acquired the Security Being Reported on by the Parent Holding Company: ----------------------------------------------- Not Applicable Item 8 Identification and Classification of Members of the Group: --------------------------------------------------------- Not Applicable Item 9 Notice of Dissolution of Group: Not Applicable ------------------------------ Item 10 Certification: Not Applicable ------------- After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 2, 2005 /S/ Louis Colen ----------------------------- Louis Colen